Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab Maintenance in Ulcerative Colitis
NCT01061996Phase 2Terminated
- Sponsor
- Cerimon Pharmaceuticals, Inc.
- Start
- Jul 2007
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of basiliximab in ulcerative colitis (UC), sponsored by Cerimon Pharmaceuticals, Inc.. Started Jul 2007; status: terminated.
02
Drugs
basiliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01061996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061996.